Collectively, these findings point to a multifaceted role of EphA5 in modulating tumor behavior across cancers, possibly through the intersection of proliferative and metabolic pathways, and suggest that its prognostic impact may vary according to tumor subtype and microenvironmental context. Here, EPHA5 is linked to neoplasm.